astra zeneca and oxford university say theirs is cheaper and easier to distribute than rivals. hello, i'm sam is a band. this is al jazeera live from doha. also coming out. if the open government forces say they're moving closer to the to grain, city of mecca, as the desperate humanitarian situation worsens for refugees. the saudi's foreign minister denies israeli media reports, israeli prime minister, met with crown prince mohammed bin sound man u.s. president elect joe biden, is set to announce his 1st cabinet appointments. anthony blinken may form on obama administration official expected to be secretary of state. powell says it's developed a covert 19 vaccine for the world and then a fraction of the cost of others in the pipeline. the british drug maker working with oxford university says trials show it could be around 90 percent effective. it would cost around $2.00 and a half dollars a dose and be stored at normal frigid temperatures for 6 months, helping distribution. by contrast, more than or says it's experimental vaccine looks to be $94.00 sent affective. it can sit i

s university of oxford using the adenovirus platform. researchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body into thinking it has been infected with the virus that causes that 19. i'm producing an immune response., over 24000 volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late stage trials show the a donor viral vaccine is better at preventing hospitalizations and severe cases of covert 19 r.n.a. vaccines developed by madonna and pfizer by on tech. but people are not getting sick with the spike scene, which means that ultimately, even if you want to get ill, you have mild symptoms. and so i think that's incredibly important because it'll keep a spittle, bence free, and people won't be dying from this in this virus. and that's not the only advantage. unlike the m.r. in a vaccines, it can be kept at normal french temperatures, making it easier to distribute, especially in developing countries. it can also be manufactured at scale, meaning it

the british drug maker working with oxford university says trials show it could be around 90 percent effective. it would cost around $2.00 and a half dollars a dose and be stored at normal frigid temperatures for 6 months, helping distribution. by contrast, modern or says it's experimental vaccine looks to be 94 and a half percent effective. it consists in the fridge for 30 days or a regular freezer for 6 months. the fine is a vaccine on the other hand, well that is said to be 95 percent effective. however, it requires specialist freezing. both maternal and pfizer will charge at least $20.00 a dose. marriott is the health policy manager and oxfam. she says the news from astra zeneca and oxford is encouraging. if they do, you really want this to be a vaccine for the world? then we have to address the elephant in the room and that is the supply issue. we don't have enough supply of this vaccine for the world. and, and, and it's true that astra zeneca has with oxford and under oxford university, it's instruction we understand have made more deals with more money factor is to scale up pr

in the early days and obviously with this process there is no guarantees so just because an oxford university with an old is a far along in the process until actually gets regulator approval is no guarantee that it's going to so 1st the market effectively just means that it's the only counted out there for now so to an extent you do get a slight advantage that said there are number of different vaccines potential vaccines out there that will be flooding this market but it's not a small market this is an entire global population will be need to need to be vaccinated or at least 70 percent of which will need to be vaccinated now over the next few years so there's going to be plenty of demand more than enough to cover the supply that's going to be provided by pfizer astra zeneca and everyone else so in that respect there's not a great deal of competition i suppose because there is enough demand to satisfy multiple producers but are they competing in a way to try to produce the most trustworthy vaccine because trust is going to be a big part of whether or not people take it up. so this is the mos

oxford university. will. stay with us. alan. sputnik 5 has the world. just like its namesake the original sputnik. the 1st draft of a to leave. orbit the world. many questions remain unanswered russia's new vaccine be a focus for the west and the family states please when you make you feel. to receive. interest preliminary requests. williams those of us from what she. writes this is happening. a window on the reaction has been exactly the same as it was waved by. journalists in the us . the world reaction is made of green cheese. but. it's. and we're talking to al trist evangelists professor of philosophy at oxford university william at mccaskey well just recently i spoke to a loss of for i'm sure you know him and he actually tells me that charity work while it is ing some lives somewhat basically perpetuates the system that makes this live miserable in the 1st place right so as if we're like guided by the principle of effectiveness it is in the end it seems much more effective for me to join let's say a political organization that would tackle inequali

william macaskill professor off the last of the at oxford university and the co-founder of the center of for effective altruism it's really great to have you with us today welcome to our show was. great to be here thank you for inviting me on so all right so the movement here associated with this called sect of altruism i mean the very notion of this active altruism makes me wonder can altruism be in the affective or even harmful and in what cases yes i think suddenly isn't very often as ineffective or even harmful so there are many attempts where people try and do some out of good but actually end up. achieving very little or just achieving far less than they could have done so for example if so that i'm in the united states called scared straight takes juvenile delinquents and shows them around prisons in order to scare them out of a life of crime but this has been studied many times over and actually it turns out that this program increases the rates of criminal activity among those teenagers in the years following the program so this is actually an example of an activity that is a

more now on the coronavirus vaccine developed by oxford university, which stops 70% of people developingfrom oxford's professor andrew pollard about the news. we've got very high effectiveness. 70% is better than the flu vaccine is in most years. we have very high effectiveness, and that is with two full doses that we get the result. the 90% is an intriguing result. when we give a half dose as the first dose, which means we have more vaccine available, after the second dose we see 90% protection. that is an exciting and intriguing result that we need to dig further into. but it really looks as if there is a vaccine which has the potential to protect against the disease. importantly, in anyone who had the vaccine, there were no admissions to hospital, no severe disease. so when we are talking about the 70% result, that is against all infection, including the milder forms of it. but there was nobody that ended up in hospital or with severe disease. the study with the low dose first, and then the full dose, we had this intriguing 90% protection. is there a possibility, then, that there is a

astra zeneca, an oxford university say theirs is cheaper and easier to distribute their rivals. if the open government forces, say they're close to the city and make a way, as the desperate humanitarian situation worsens for refugees. a trial begins for former french president nicolas sarkozy, accused of corruption in a phone tapping scandal. another record high for greenhouse gases in the atmosphere. and they're still growing despite industries shutting down during the pandemic. and in school the presidents of african football and it has been banned for 5 years. football's governing body finding i'm guilty of breaching its code of ethics. now astra zeneca say they've developed a code with 19 vaccine for the world and a fraction of the cost of others in the pipeline. the british drug maker working with oxford university says trials show it could be around 90 percent effective. it would cost around $2.00 and a half dollars a dose and be stored in normal, frigid temperatures for 6 months, helping distribution. by contrast, modernise says it's experimental vaccine looks to be 94.5

s university of oxford using the a don't know virus platform. researchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body into thinking it has been infected with the virus that causes that 19 producing an immune response., over $24000.00 volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late stage trials show the adenovirus vaccine is better at preventing hospitalizations and severe cases of covert 19 m.r. in a vaccines developed by madonna and pfizer by on tech. but people are not getting sick with the spike scene, which means that ultimately, even if you were to get ill, you have mild symptoms. and so i think that's incredibly important because it will keep hospital beds free and people won't be dying from this from this virus. and that's not the only advantage. unlike the m.r. in a vaccines, it can be kept at normal french temperatures, making it easier to distribute, especially in developing countries. it can also be manufactured at scale, meaning it c

it came from oxford university. scientific progress in the uk, and make sure that the vaccine industry in the uk is really underpinned and grows well. professor robin shattuck, sorry to have lost your image, but great to be able to still talk to you, thank you so much for talking to us. my pleasure. the prime minister will also introduce mass testing for all areas in tier three. mrjohnson will say rapid testing with military support, as used in liverpool, will form part of the stricter system. testing will also be rolled out for care home visitors across england from next month, with every care home resident able to have two visitors tested twice a week. it means people who live in care homes will be able to hug relatives by the end of the year, the government has said. and we'll be answering your questions on covid vaccines and testing here on the bbc news channel at 11:30. do send your questions using the hashtag #bbcyourquestions or email them using yourquestions@bbc.co.uk. we'll be putting them to our experts at

also coming up oxford university in astra zeneca admit errors in how they administered vaccine trials raising questions about their findings. warns germany's coronavirus restrictions could remain in place well into next year. and huge crowds gathering in the arjun time capsule to pay tribute to football legend daughter. after he died of a heart attack. 60 prime minister has ordered the final phase of the offensive on the northern region to begin in the statement telling residents to stay indoors as the army is ordered to move on. so mckayla a government imposed deadline for the grand forces to surrender, expired on wednesday. be nearly 3 weeks of fighting with hundreds killed and tens of thousands displaced. what's agree is a northern semi autonomous region of ethiopia. it's a great people's liberation front govern the region and are estimated to have up 225-0000 faces. they had controlled the national government for nearly 3 decades before prime minister to power in 2018 to grey was the front line for ethiopia and its decades long conflict with eritrea and large amounts of military e

nasdaq futures up 50 the markets are getting a boost this morning on news from astrazeneca and oxford universityt broke just hours ago. the university saying its covid-19 vaccine was found to be as much as 90% effective in preventing infections without serious side effects in a large clinical trial in the uk and brazil efficacy rates from 62% to 90% depending on the dosage given. headlines from an on going news conference with the vaccine developers right now, this vaccine can be easily distributed and is stable at normal refrigerated conditions that's important because transporting it at super cold conditions is hard and expensive. this one needs no more than a refrigerator, like moderna they expect to have more than 200 million doses of an active vaccine by the end of this year and plan to manufacture up to 3 billion doses. on a time frame, they will begin talking to the u.s.'s food and drug administration later on this week about formal approval. very, very good news all around. meantime two other leading vaccine candidates shown to be 90% effective in late stage trials the one from pfizer an

this time from the drug company astra zeneca working in partnership with oxford university. they staged testing shows. its candidate vaccine is on average 70 percent effective in protecting against code 19, but that increases to 90 percent depending on the way it's administered. russia's and it has vaccine is the least expensive so far. and crucially, it can be stored in the fridge, which makes it easier to distribute on the vaccines need to be stored at much lower temperatures. the firm says it can have up to 200000000 doses ready by the end of the year. possibly 3000000 by 2021. turn how reports it's being hailed as a vaccine for the world pharmaceuticals firm astra zeneca in partnership with the university of oxford says interim trial results will be sent to regulators immediately in the hope their product is approved for rollout before the end of the year. we've got a vaccine, which is a fact it prevents a live action. and intriguingly, in result of a headline is that we do have, as are our and then of all those of the where we saw 90 percent or more data may be needed t

university of oxford.esearchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body thinking it'd has been infected with the virus that causes covid-19 and producing an immune response. over 24,000 volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late-stage trials sw the vaccine is better at preventing hospitalizations and severe cases of covid-19 than the mrna vaccines developed by moderna and pfizer-biontch. >> people are not getting sick. even if you were to get you would have mild symptoms and that is important to keep hospital beds free, and people will not be dying from this virus. >> that is not the only advantage. it can detect abnormal fridge temperatures, making it easy to distribute, especially in developing countries. it can also be manufactured at scale -- meaning it can be produced in much greater quantities and much lower -- at much lower costs than its rivals. >> i think it will be truly global vaccine i

oxford university announces that its covid vaccine works. boris johnson says its fantastic news. overall, the vaccine is 70% effective, and in some dosages 90%. it's also cheaper and easier to store than those already announced. it really looks as if there's a vaccine which has the potential to protect against the disease. and importantly, in anyone who had the vaccine, there were no admissions to hospital, no severe disease. we'll be getting reaction from our medical editor. also this lunchtime: with one more week of lockdown in england, borisjohnson prepares to tell us what's coming next. daily coronavirus tests will be offered to close contacts of people who have tested positive in england to reduce the current 14—day quarantine. we report from melbourne, the australian city which accounted for 90% of the country's covid deaths, on the success of its "hard and fast" lockdown the hero of london bridge tells us how he fought the attacker with a narwhal tusk. this has impacted me, i've gone through bouts of depression and sleep is the challenging one, where my brain won't shut of

oxford university and a astrazeneca revealing the vaccine they're developing shows a strong immune response in older people. jobina, this is important since these are the people so vulnerable to the virus. >> older people are more likely to have underlying health conditions that make coronavirus more dangerous. having a vaccine just as effective in older and younger patients is significant here. participants also showed few side effects. the last steps of oxford's phase three trial are under way now so they could be seeking approval for the vaccine in a matter of weeks. this comes as america's death toll popptopped 250,000 people. the largest school district in new york city is going back to virtual learning in hopes of curbing the spread. oregon, michigan an minnesota are joining the growing list of those ordering new restrictions. governors are urging americans to rethink thanksgiving plans. >> you know what love is on thanksgiving? i love you so much thankful for you that i'm not going to see you. >> tensions over the presidential transition continued to raise concerns about how quickly

back now to the development of the oxford university vaccine which is very good news.th correspondent catherine burns has been answering your questions. there is no such thing as a vaccine thatis there is no such thing as a vaccine that is 100% effective for every single person. researchers trying to find a vaccine for coronavirus were set a target, to make it at least 50% effective. this oxford vaccine averages out at about 70%, so it has done that and then some. so how does it stack up against other vaccines? there is a range. the flu tends to be about 40—60% effective. at the other end of the scale chickenpox is about 98% effective for children. the important thing to remember is that this vaccine has been shown to be highly effective. some people are asking, how can scientists be so confident in a vaccine they have come up with in less than a year? a lot of it comes down to cash. there has been a huge global effort with massive amounts of money. but also brain power. these vaccines that we are seeing now have been through all the usual processes, just streamlined.

the company has been developing the vaccine with oxford university and humans who have launched a missile at an iraqi fuel distribution station in saudi arabia's port city of jeddah, the videos circulating on social media claim to show a large fire in the city. saudi arabia's neither confirmed nor denied the claims, but a spokesman says foreign companies operating in the area should exercise caution. they warn military operations will continue. fall is here with the news hour in about 25 minutes time on al-jazeera, next as witness. on countering the cost becomes the 1st african nation to default on its debts and the pandemic other steps pile up. central banks think the unthinkable. negative interest rates plus brazil has dumped the rankings of the world's top 10, economies countering the cost on al-jazeera. people are way inclined to take it in the wind with putting us spades everywhere, but that does that. they can't ignore burns. we went out to the hard to find displays because we know to what tell lies and no contest to those who most of those who just like the business or decide is an

imran: the astrazeneca-oxford university study will be published in "the lancet." do think once transparency is in place, once we see the data, do you think that will help? >> certainly. i think peer-reviewed is absolutely essential. i think one of the challenges we face with many of the vaccines is many companies may claim results before it is peer-reviewed. that is a challenge. that has led to some discord in the scientific community as well as the public. i think there will be a different perspective in terms of the astrazeneca vaccine as an example. the public can be confident this is not one or two companies pursuing a particular agenda, but the data coming out. to scientific scrutiny. imran: dr. davis, is there anything about this timeline that concerns you, the speed at which these vaccines could potentially get to market? >> that does not concern me. people need to realize we have been manufacturing vaccines for years and years, and multiple checks and balances are put in place. i've talked about the uniqueness of the situation. that uniqueness need not be

the deal that was signed between the university of oxford and astra zeneca was intended to supply factsin a to go play will scale. the deal that we have with us to senate means that the university doesn't profit from the sale of this vaccine. while the pandemic is happening and that we will never profit from this vaccine, from the sale of it to, you know, middle income countries because we wanted you want this to be a vaccine for the whole world. there was kitty, you were speaking with me earlier. if you o.p.'s government is warning residents of the embattled, the region that anything can happen as the clock ticks down on its alter, made of the government has given forces until wednesday to lay down their arms or face an assault on the regional capital. but the people's liberation front has vowed to keep on fighting. the un fears 200000 people could flee to neighboring sudan because of the conflict. ethiopian forces pushed further into the to grow region. the advance has not been a challenge as the degree of battle on the roadside attests. but the government and addis ababa is confident

the vaccine was developed at the ukase university of oxford using the a don't know virus platform. researchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body into thinking it has been infected with the virus that causes that 19. i'm producing an immune response. so, for $24000.00, volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late stage trials show the a done a viral vaccine is better at preventing hospitalizations and severe cases of covert 19 than the m.m.r. in a vaccines developed by maternal and pfizer by on tech. but people are not getting sick with the spike scene, which means that ultimately, even if you were to get ill, you out model symptoms. and so i think that's incredibly important because it'll keep hospital beds free and people won't be dying from this in this virus. and that's not the only advantage. unlike the m.r. in a vaccines, it can be kept at normal, frigid temperatures, making it easier to distribute, especially in developing countries. it can also be manufactured a

meanwhile, oxford university and astra zeneca admits error is in how they administered vaccine trials raising questions about their findings and police in india's capital. those borders asked thousands of fall must protest against laws. they say what affects their livelihoods. and joining us, roscoe with sports as tributes pour in for diego maradona. we look back at the career of the argentine legend, want to have made him such a special football player. thank you very much for joining us. ethiopia's foreign minister says the final phase of the offensive on the norgate northern to grey region. as begun in a statement made is telling residents to stay indoors as the army is ordered to move in on the regional capital make a government imposed deadline fatigue. re-enforce sister surrender expired on wednesday of a nearly 3 weeks of fighting with hundreds killed and tens of power disgraced. let's take a closer look at where all this is happening to gray is in northern semi-autonomous region of ethiopia. the tea, great people's liberation front govern the region and are estimated to have u

oxford university, which partnered with the firm, says some of the trial injections did not have theht amount of vaccine due to a manufacturing error. the university says it has discussed the problem and agreed to complete the late stage trial with two groups. the world health organization's executive director says a vaccine will allow for greater control but michael ryan warned a vaccine one not mean the virus is over. he appealed for continued physical distancing measures to avoid further lockdowns. i spoke to a vaccine allergist and vice president have -- and vice president at blue willow logix. he says people must continue to follow the rules. >> i think there is a big problem if we relax and say we have a vaccine and everything is ready and we can go out and start our life as it used to be. that is a kind of big mistake for everybody because having a vaccine is one thing and applying the vaccine to the community and to almost everybody is a huge task. that would take months. if we just relax today because we have the results from a clinical trial, that is something that should b

learning about oxford and astrazene astrazeneca's vaccine, of course its efficacy. >> this is the moment we've all been waiting for for many, many months, what are the results for the universityrazeneca vaccine. the results are in for the early data. this is just the headline stuff. overall the efficacy number is 70%. now, you can compare that to moderna's which is 94.5 and pfizer which is 95%. it does look disappointing. however, this is an average of different doses they tried out through the phase two and phase three trial in the uk and brazil. really interesting, those participants that were given half a dose and four weeks later got a full dose, the efficacy results for that was 90%. but two full doses, it was 62%. so, now astrazeneca are looking to focus much, much more on this idea of having a half dose and then a full dose. and they can start to incorporate that into the phase three trial that's ongoing in the united states. it is good news. they are very pleased with this result. they are now submitting all this data to the regulatory bodies all around the world to try and get approval. there were no big adverse negative effects. that's obviously very, very important

new phase three results from oxford university shows that a vaccine candidate has 70% effectiveness in preventing covid-19. researchers say the number may be as high as 90% when tweaking the doses. while it's less than both pfizer and moderna's vaccine results, which each company says is 95% effective, that company says its vaccine can be kept at refrigeration temperatures. that could make it easier to store for many hospitals. both pfizer and moderna's vaccines must be stored in much colder conditions. >>> and the governor and his family are quarantining for 14 days after being exposed to the virus. the governor tweeted late last night that although the entire family has tested negative, they will follow the guidance. this comes after three of newsom's children were exposed to a chp officer who tested positive for covid-19. newsom and his wife had no direct interaction with the officer but days ago we did learn one of newsom's children was quarantined for possible exposure. the governor is facing heavy criticism for his decision to attend birthday dinner as restrictions tighten around

cope with 19 and the drug maker, astra zeneca says the vaccine it has developed with universe oxford university is up to 90 percent effective. and that it's cheap to make time easy to store china launches an unmanned spacecraft to the moon, the mission to bring the rockets back to earth. we asked 8 rocket scientists what success would mean for china's i'm speechless space? i'm probably a phony. yes. welcome to the program. we start in the united states where a key federal agency has told joe biden the presidential transition can begin. after donald trump directed his administration to cooperate in the handover process . in a tweet, president, trump said he no longer opposed government aid for biden's transition team. it's the closest yet he's come to conceding defeat. earlier us president elect joe biden announced his nominations for 6 top positions in this administration. a long time advisor anthony blinken for the position of secretary of state, former secretary of state john kerry as climate change on voice. and john together as treasury secretary, when it comes to well for more on this son

this time from oxford university and astrazeneca.nary results in their tr ials show this vaccine is 70% effective. in subgroup of volunteers who received a half dose followed by full dose the effectiveness rose to 90% andhat two dose programve may ther benefits, too program may have other benefits. >> and there is also a really interesting hint that that regimen is also unable to reduce -- able to reduce asymptomatic infectionto it may get u pce where it cannot transmm person-to-person. >> these results follow two other vaccine announcements. pfizer collaborating with the german company biontech we the first to announce and then moderna. bo vaccines have been shown to be 95% effective. however, the oxford vaccine is cheaper and it is easier to store as well. crucially, it cante k at fridge tempfrature. ther vaccine has to be stored at -70 drees. this oxford vaccine is also simple to make according to astrazeneca. >> i think one of the real benefits of this vaccine is the fact that we can manufacture to scale. it's ay relativasy vacci

. >> astrazeneca and oxford university are defending the results and methods. they claimed the drug to be 90% effective and later admitted to contradictory numbers for different trials. scientists question why some people in the trials were only given half doses. a spokesperson is saying studies were conducted to the highest standard but they were interim results. they tell bloomburg they are considering a new study. >>> it is 6:08. millions of murss went to work at hospitals. the covid cases put major stress on health care industries when it comes to shortages. 261,000 lives lost, nurses worried about their own families and often feel exhausted and helpless. >> one of the things we struggle with is what do we do with our kids if we feel we can't keep them safe, potentially sending them to live with a relative away from us. >> when i get a chance when i'm not in a room if i can run into the bathroom for a 30-second break, i'll quickly take the mask off and shield and breathe, breathe, breathe, breathe. >> with the large number of people traveling hospitals are

oxford university, a drug company astra zeneca could be up to 90 percent effective and cheaper than to other u.s. vaccines. drug company has pledged not to make a profit from the vaccine during the pandemic raising hopes it could be distributed more widely across the world. pharmaceutical firms of pfizer, have a reported about 95 percent efficacy from late stage trials of their experimental vaccines to whole reports from london. it's being hailed as a vaccine for the world pharmaceuticals firm astra zeneca in partnership with the university of oxford says interim trial results will be sent to regulators immediately in the hope their product is approved for rollout. before the end of the year. we've got a vaccine, which is a fact it prevents a live action intriguingly in result of a headline is that we do have as our are and then have all those of the back. and i guess where we saw 90 percent or more data may be needed to confirm the 90 percent subgroup results, but cheaper to mass produce, easier to distribute, to more moderate temperatures than its competitors. the british vaccine is

the company has been developing the vaccine with oxford university and says it can be stored at fridge temperatures, making it easier to distribute the u.k.'s health secretary, matt hancock, says $100000000.00 doses are on order and could start to be rolled out from next month. let's bring in john a whole line for us in london. so join a more important vaccine news. but what about the results? well, largely as you've laid them out there with a couple of specific kaviak, what one that astra zeneca, the pharmaceutical company that partnered with oxford university to produce this vaccine have said this morning that they received the great caution data on saturday night is still a lot of it to stroll through trolls through in order to try and understand a discrepancy over dosing regime. one dosing regime, which is off a dose, followed by a full dose a month later produces an effect efficacy up to 90 percent. the other dosing regime, one full dose, followed by another full dose, a month apart, produces much lower results, so they have gone for the moment with the average efficacy figure of

now during a video conference call, representatives from astra zeneca and oxford university spoke about distribution and how competition among vaccine developers was actually welcome. and we've always known that we don't need multiple back scenes for the world because no one develops and i will manufacture is going easy enough to cover everywhere. and so having multiple back scenes and basically with different manufacturing technologies and technologies that can be manufacturers' globally and distribute it likely that's really important sometimes to court fingered competition. but if you have the capacity, the highs and all the capacity plus our capacity, which is much bigger, the 3 of us don't even have enough thanks in part of the.

this is about the oxford university vaccine that we have heard so much about in recent months. have heard about already, the pfizer and madonna vaccines. but in a subgroup of volunteers who received a half dose, followed by a full dose, the effectiveness rises to 90%. that is the information that we are getting here this morning about the oxford university vaccine, just coming in the last few moments. iam sure just coming in the last few moments. i am sure that number might sound like a bit of a disappointment, but the oxford jab maggie is cheaper, it is easier to store and i'm sure there are other things we can speak to the health secretary about with regards to that. i am sure he will tell us it will still play a significant role in tackling the pandemic if of course it is approved by... will get some word from matt hancock about that later. breaking news this morning. astrazeneca, who are working on a drug with 0xford university, say their vaccine is shown to be 70% effective when preventing covid—19. and we will actually be talking to fergus walsh before we come off the air

the important update from oxford university. >>> and should california thin the forests after this year's catastrophic fire season? the debate rolls on. we investigate the hurdles that prevent it from happening. >>> i'm chief meteorologist jeff ranieri. i'll show you how cold it gets for tomorrow morning and where the rain is headed for thanksgiving. i'm back in about 8 minutes. >>> it's become a political issue, but this is really an issue about our fire safety. the debate rages on. should california be fighting back by preemptively thinning our forests? there's a lot of evidence that better forest management will help. even governor newsom admits that. but it comes at a steep cost. our investigative reporter has the inside story. >> it does break my heart to see so many old dead trees. >> reporter: retired forest fire chief michael beasley in yosemite national park with a model program that involves setting the forest on fire under controlled conditions to stave off extreme wildfire later. but budget cuts meant the yosemite crews weren't able to get to the park's northern entrance befor

a shot developed with oxford university can be stored at fridge temperatures.

the company has been developing the vaccine with oxford university. importantly says it can be stored at frigid temperatures, making it easier to distribute the u.k. health secretary, matt hancocks, is 100000000 doses are on order and it could start to be rolled out next month. john, how in london to talk us through that when it all sounds pretty good. just one about the word and it can be up to 90 percent effective if you got more data. yeah, it's important that astra zeneca, the british pharmaceutical company that partnered with the university of oxford said this morning when they announced these results that there was a discrepancy between different possible dosing regimes. producing results between the early sixty's percent range up to 90 percent said they in fact asked to have gone with an average efficacies rate of 70 percent, which is less, it has to be said than the pfizer and modernity. vaccines vying for regulator approval in the united states. nevertheless, a hugely important breakthrough this, according to astra zeneca, 1st of all, no seri

corona virus vaccine this time from the drug company astra zeneca working in partnership with oxford university late stage testing shows its candidate vaccine is on average 70 percent effective in protecting against curb 19, but that increases to 90 percent depending on the way it's administered. asters that it has a vaccine is the least expensive so far. and crucially, it can be stored in the fridge, which makes it easier to distribute other vaccines need to be stored at much lower temperatures. the firm says it can have up to 200000000 doses ready by the end of the year, possibly 3000000000 by 2021. turn how reports it's being hailed as a vaccine for the world pharmaceuticals firm astra zeneca in partnership with the university of oxford says interim trial results will be sent to regulators immediately in the hope their product is approved for rollout before the end of the year. we got a vaccine, which is a fact it prevents severe disease intriguingly in result, protection. we do have as are our own. and then of all those of the back and i was aware we saw 90 percent or more data may be neede

william macaskill professor off the loss of a at oxford university and the co-founder of the center of for effective altruism it's really great to have you with us today welcome to our show was. great to be here thank you for inviting me on so all right so the movement here associated with this called sect of altruism i mean the very notion of this active altruism makes me wonder can altruism in the affected or even harmful and in what cases yes i think senator lee who isn't very often is ineffective or even harmful so there are many attempts where people try and do some out of good but actually end up. achieving very little or just achieving far less than they could have done so for example a program in the united states called scared straight takes juvenile delinquents and shows them around prisons in order to scare them out of a life of crime but this has been studied many times over and actually it turns out that this program increases the rates of criminal activity among those teenagers in the years following the program so this is actually an example of an activity that is active

overall results from oxford university and astrazeneca's vaccine trial — show it protects 70% of people

the 3rd major covert 19 vaccine of reveal the results of the late stage trials as the one from oxford university and the drug company, astra zeneca, which say their vaccine is on average 70 percent effective. but depending on the dosage that can go up to 90 percent at 2 dollars and 50 cents, it's a lot cheaper as well than the 2 u.s. vaccines. the company has pledged not to make a profit from the vaccine during the pandemic raising hopes it could be distributed distributed more widely around the world. earlier this month we had the american pharmaceutical firms find that and madonna, they reported about 95 percent effectiveness in the late stage trials of their experimental vaccine that's has a report on the new vaccine from london. it's being hailed as a vaccine for the world pharmaceuticals firm astra zeneca in partnership with the university of oxford says interim trial results will be sent to regulators immediately in the hope their product is approved for rollout. before the end of the year, we got a vaccine, which is a fact it prevents severe disease. intriguingly, in results for over a he

british drug company ash zeneca an oxford university say late stage testing of their coded 19 vaccine shows it's highly effective. they say it could be stored at frigid temperatures, making it cheaper and easier to destroy. leaders in ethiopia, a growing region denying government claims that the military is surrounding the regional capital, like a prime minister. has given that he grave people's liberation front until wednesday to surrender or face an assault on the city. it's home to around half a 1000000 people. now the t.p. l. f has so far refused to stand aside, saying its people are ready to die in defense of their land. sydney's authorities are hoping 2 camps to cope with the influx of refugees from ethiopia, and morgan reports state many have been displaced. refugee camp in sudan's got out of state is need too many refugees, but not it has this fight. her parents fled to the camp in 1085 to escape war and famine back in their home country. she's back to the same old camp this time with her 10 day old child who she gave birth to while fleeing conflict in ethiopia degrade region.

oxford university which partnered with the pharmaceutical firm, says some of the trial of injections didn't have the right amount of vaccine due to a manufacturing error. the university says it's discussed the problem with regulators and agreed to complete the late stage trial with 2 groups. the u.k.'s chief medical advisor says he remains confident in the trial results so far. ready to put the whole thing. they'll see the top of the result set, as he said. and we've got a great privilege if you k. no look at no, don't make their decisions around. so i think, you know, one results this vaccine works. i don't know, it's very exciting and it's going to be put forward for approval. regulators will need to decide not to be truthful about the world health organizations, executive director says a vaccine will allow for greater control over the krona virus. but mike ryan warned that a vaccine won't mean the virus is over. people to be mindful of behavior that increases the spread of the virus over the holidays. and he appealed for continued physical distancing measures to avoid further lock

now during a video conference call, representatives from astra zeneca and oxford university spoke about distribution and how competition among backseat developers.

and we're talking to al trist evangelists professor of philosophy at oxford university william at mccaskey well just recently i spoke to a loss of for i'm sure you know him and he actually tells me that charity work while it is ing some lives somewhat basically perpetuates the system that makes this live miserable in the 1st place right so as if we're like guided by the principle of effectiveness it is in the end it seems much more effective for me to join let's say a political organization that would tackle inequality or other fault so the system instead of giving to charities that it will only fix the symptoms but not the illness do you know what i mean or not that it's really being snotty isn't yet. so i think the key thing here is to say that you just can direct charitable money towards fixing the root talking rather than just the symptoms so this has a long history. even i coul marks when writing does capital he was funded by as a tangle acting as a philanthropist marx wouldn't have been able to do the work he did whether or not that's on top a contribution and so similarly if you're

the vaccine was developed at the ukase university of oxford using the a don't know virus platform. researchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body into thinking it has been infected with the virus that causes that 19 producing an immune response., over $24000.00 volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late stage trials show the a donor viral vaccine is better at preventing hospitalizations and severe cases of covert 19 than the m.m.r. in a vaccines developed by madonna and pfizer. by on tech, but people are not getting sick with the spike scene, which means that ultimately, even if you were to get ill, you have moral symptoms. and so i think that's incredibly important because it'll keep ospital birds free and people won't be dying from this virus. and that's not the only advantage. unlike the m.r. lay vaccines, it can be kept at normal, frigid temperatures, making it easier to distribute, especially in developing countries. it can also be manufactured at scale, meaning

the news comes as oxford university announces that its covid vaccine works. the vaccine is 70% effective and, in some dosages, 90%. it's just gone five o'clock. in the last hour the prime minister has made a statement outlining his post—lockdown plans for england. boris johnson announced the current national lockdown restrictions will end on december 2nd. from next wednesday people will be allowed to leave their home for any purpose and can meet up to six people from other households in outdoor spaces. collective worship, weddings and outdoor sports can resume, and gyms and non—essential shops will be allowed to reopen. the prime minister also announced that outdoor and indoor sports venues in tiers one and two will be allowed to welcome a limited number of spectators after 2nd december, with a maximum of 4,000 fans allowed to attend outdoor events in the lowest risk areas. but there will be a return to tougher regional tier restrictions — an announcement on which areas fall into which tiers is expected on thursday. those in tier1 will be encouraged to work f

in the next half hour, more good news about a vaccine from oxford university and astrazeneca. >>> new at 6:00, two bay area cities are among nine in california at high risk for serious financial problems in the next several years. richmond and el cerrito are considered code red cities. according to the "san francisco chronicle." richmond ranks fifth and el cerrito sixth on the most troubled cities. the ratings are based on ten factors including city debt, rainy day funds, pension obligations and expected revenue. >>> two north bay parents are heading to prison for paying $250,000 to get their daughter into usc. diane and todd blake live in ross, marin county. is judge sentenced her to six weeks, he got four months. the couple pleaded guilty to conspiracy charges as part of a plea agreement. they each also agreed to pay a $125,000 fine plus perform 100 hours of community service. the blakes were accused of pretending their daughter was a volleyball recruit to get her into usc. >>> lori loughlin's husband, massimo giannulli is expected to report to prison today. the 57-year-old fashion

scientists at oxford university working alongside pharmaceuticals. astra zeneca say trollers their vaccine candidate is 70 percent effective, but that is thought to rise as high as 90 percent one and a half doses a given that is lower than the percentage is given by pfizer by on tech. and however, the oxford vaccine is cheaper to produce and it's easier to store on robots for any other developments on the virus to go to our website. steve, to me dot com slash covers 19 thanks for joining us on the college. 19 special. take out smartphones in the dark. dark mode is meant to protect our eyes, preserve our batteries, and help us sleep better. but researchers aren't convinced the book in the dark mood really do to morrow today is going to minutes on w. . every day counts for us and for our planet as it is on its way to bring you more conservation playground to make signals green. how can we protect habitats? we can't make a difference in the line has an environmental series in global 3000 on t.w. and online to use crime fighters are back to africa's most

calling for a rise after more good news about vaccines this time from astrazeneca and oxford universitye dow will start the day at 29,263. the nasdaq and s&p lower friday as hospitalizations hit new records. we're running about one fatality a minute here in the u.s. one of the key differences between the new vaccine and the two that you've already heard about the astrazeneca vaccine is not mrna, the other two are. that gives us a look at a different way of developing a vaccine and the more the better. guitar center is the latest large retailtory file for chapter 11 bankruptcy. the stores will remain open as they try to renegotiate debt. a bit ironic because a guitar maker says sales were climbing as people stayed home and learned the new hobbies. lots of people learning guitar. cnbc says lawyers for elizabeth holmes want to prevent prosecutors from telling the jury in her fraud case about her use of personal assistants and other habits of the wealthy. they say her wealth, at the time anyway, is not an indication of guilt or innocence. she's not wealthy now. her company theranos collapse